D

Daewoong Co Ltd
KRX:003090

Watchlist Manager
Daewoong Co Ltd
KRX:003090
Watchlist
Price: 20 900 KRW -1.88% Market Closed
Market Cap: 854.6B KRW
Have any thoughts about
Daewoong Co Ltd?
Write Note

Daewoong Co Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Daewoong Co Ltd
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
D
Daewoong Co Ltd
KRX:003090
Total Liabilities & Equity
â‚©2.7T
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
11%
Yuhan Corp
KRX:000100
Total Liabilities & Equity
â‚©2.9T
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
6%
SK Biopharmaceuticals Co Ltd
KRX:326030
Total Liabilities & Equity
â‚©723.2B
CAGR 3-Years
13%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Total Liabilities & Equity
â‚©2T
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
7%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Total Liabilities & Equity
â‚©493.3B
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
11%
C
Celltrion Pharm Inc
KOSDAQ:068760
Total Liabilities & Equity
â‚©652.6B
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
5%
No Stocks Found

Daewoong Co Ltd
Glance View

Market Cap
854.6B KRW
Industry
Pharmaceuticals

Daewoong Co., Ltd. engages in the management of its subsidiaries. The company is headquartered in Seongnam, Gyeonggi-Do. The firm operates its business mainly through subsidiaries including Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd, Daewoong Development Co Ltd, and Hanall Biopharma Co Ltd. Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd and Hanall Biopharma Co Ltd are engaged in the manufacture and sale of pharmaceuticals. Daewoong Development Co Ltd is engaged in real estate rental and supply business. In addition, IDS&Trust Co Ltd manufactures and sells communication-related devices. Daewoong Life Science Co Ltd is engaged in food processing and sales. Pampaeg Co Ltd is engaged in the packaging business of quasi-drugs. Daewoong Management Development Institute Co Ltd is engaged in management and industrial training projects.

Intrinsic Value
24 259.07 KRW
Undervaluation 14%
Intrinsic Value
Price
D

See Also

What is Daewoong Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
2.7T KRW

Based on the financial report for Sep 30, 2024, Daewoong Co Ltd's Total Liabilities & Equity amounts to 2.7T KRW.

What is Daewoong Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
11%

Over the last year, the Total Liabilities & Equity growth was 16%. The average annual Total Liabilities & Equity growth rates for Daewoong Co Ltd have been 12% over the past three years , 10% over the past five years , and 11% over the past ten years .

Back to Top